Drug screening using shape-based virtual screening and in vitro experimental models of cutaneous Leishmaniasis. Issue 1 (7th January 2021)

• Record Type: Journal Article
• Authors: Cardoso Santos, Camila; Meuser Batista, Marcos; Inam Ullah, Asma; Rama Krishna Reddy, Tummala; Soeiro, Maria de Nazaré Correia
• Is Part Of: Parasitology. Volume 148:Issue 1(2021)
• Page Start: 98
• Page End: 104
• Publication Date: 2021-01-07
• Subjects: Cutaneous leishmaniasis, -- in vitro experimental chemotherapy, -- Leishmania amazonensis, -- shape-based virtual screening; Parasitology -- Periodicals; Electronic journals; 616.96
• DOI: 10.1017/S0031182020001900
• Languages: English
• ISSNs: 0031-1820

Abstract

Abstract: Cutaneous leishmaniasis (CL) is one of the most disregarded tropical neglected disease with the occurrence of self-limiting ulcers and triggering mucosal damage and stigmatizing scars, leading to huge public health problems and social negative impacts. Pentavalent antimonials are the first-line drug for CL treatment for over 70 years and present several drawbacks in terms of safety and efficacy. Thus, there is an urgent need to search for non-invasive, non-toxic and potent drug candidates for CL. In this sense, we have implemented a shape-based virtual screening approach and identified a set of 32 hit compounds. In vitro phenotypic screenings were conducted using these hit compounds to check their potential leishmanicidal effect towards Leishmania amazonensis ( L. amazonensis ). Two (Cp1 and Cp2) out of the 32 compounds revealed promising antiparasitic activities, exhibiting considerable potency against intracellular amastigotes present in peritoneal macrophages (IC50 values of 9.35 and 7.25 μ m, respectively). Also, a sterile cidality profile was reached at 20 μ m after 48 h of incubation, besides a reasonable selectivity (≈8), quite similarly to pentamidine, a diamidine still in use clinically for leishmaniasis. Cp1 with an oxazolo[4, 5-b]pyridine scaffold and Cp2 with benzimidazole scaffold could be developed by lead optimization studies to enhance their leishmanicidal potency.